Fisher & Paykel Healthcare Corporation Limited (ASX:FPH)

Market Cap	19.69B
Revenue (ttm)	1.89B
Net Income (ttm)	383.13M
Shares Out	n/a
EPS (ttm)	0.65
PE Ratio	51.40
Forward PE	46.05
Dividend	0.41 (1.25%)
Ex-Dividend Date	Dec 3, 2025

Volume	598,582
Average Volume	578,369
Open	33.09
Previous Close	33.02
Day's Range	32.64 - 33.16
52-Week Range	29.08 - 35.75
Beta	0.86
RSI	54.50
Earnings Date	Nov 25, 2025

About ASX:FPH

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilatio...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1934
• Employees: 7,440
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: FPH

Financial Performance

In 2024, ASX:FPH's revenue was 2.02 billion, an increase of 15.96% compared to the previous year's 1.74 billion. Earnings were 377.20 million, an increase of 184.46%.

Financial numbers in NZD